NCT04029818View on ClinicalTrials.gov

Evaluation of a Probiotic on LDL-cholesterol Levels

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 24, 2019

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Cardiovascular DiseasesLDL-cholesterol
Interventions
BIOLOGICAL

Bifidobacterium BSL_PS404

Each participant will consume 1 capsule daily at lunch for 8 weeks.

BIOLOGICAL

Placebo

Each participant will consume 1 capsule daily at lunch for 8 weeks.

Trial Locations (1)

18016

Hospital San Cecilio, Granada

All Listed Sponsors
lead

Biosearch S.A.

INDUSTRY

NCT04029818 - Evaluation of a Probiotic on LDL-cholesterol Levels | Biotech Hunter | Biotech Hunter